Investigation into the effects of FK352 (a novel adenosine-1 receptor antagonist) in cirrhotic patients with ascites: A pilot study

被引：0
|
作者：
Stanley, AJ [1 ]
Forrest, EH [1 ]
Dabos, KJ [1 ]
Hayes, PC [1 ]
机构：
[1] ROYAL INFIRM,DEPT MED,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
来源：
HEPATOLOGY | 1996年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1284 / 1284
页数：1
相关论文
共 50 条
  • [1] Natriuretic effect of an adenosine-1 receptor antagonist in cirrhotic patients with ascites
    Stanley, AJ
    Forrest, EH
    Dabos, K
    Bouchier, IAD
    Hayes, PC
    GASTROENTEROLOGY, 1998, 115 (02) : 406 - 411
  • [2] PROTECTIVE EFFECTS OF FK352, AN ADENOSINE-A1-RECEPTOR ANTAGONIST, ON EXPERIMENTAL ACUTE-RENAL-FAILURE IN RATS
    KOHNO, Y
    MINOURA, H
    TERAI, T
    KUSUNOKI, T
    HORIAI, H
    OHTSUKA, M
    SHIMOMURA, K
    FASEB JOURNAL, 1995, 9 (04): : A686 - A686
  • [3] A novel adenosine A1 receptor antagonist, FK352 ameliorates contrast media-induced renal vasoconstriction through tubuloglomerular feedback (TGF) suppression
    Kawabata, M
    Haneda, M
    Kashima, Y
    Imai, M
    Takabatake, T
    JOURNAL OF HYPERTENSION, 2000, 18 : S98 - S98
  • [4] Adenosine A1 receptor antagonist, FK352 prevents contrast media-induced renal vasoconstriction under systemic NOS inhibition.
    Kawabata, M
    JOURNAL OF HYPERTENSION, 2000, 18 : S97 - S97
  • [5] RENAL EFFECTS OF FK453 - A POTENT NONXANTHINE ADENOSINE A(1) RECEPTOR ANTAGONIST
    TERAI, T
    KITA, Y
    KUSUNOKI, T
    ANDOH, T
    NAGATOMI, T
    HORIAI, H
    AKAHANE, A
    SHIOKAWA, Y
    YOSHIDA, K
    DRUG DEVELOPMENT RESEARCH, 1995, 36 (01) : 25 - 34
  • [6] Discovery of FK453, a novel non-xanthine adenosine A(1) receptor antagonist
    Akahane, A
    Katayama, H
    Mitsunaga, T
    Kita, Y
    Kusunoki, T
    Terai, T
    Yoshida, K
    Shiokawa, Y
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (17) : 2059 - 2062
  • [7] FK453: A novel non-xanthine adenosine A(1) receptor antagonist as diuretic
    Terai, T
    Kusunoki, T
    Kita, Y
    Akahane, A
    Shiokawa, Y
    Kohno, Y
    Horiai, H
    Uehara, Y
    Yoshida, K
    CARDIOVASCULAR DRUG REVIEWS, 1997, 15 (01): : 44 - 58
  • [8] Systemic, portal and renal effects of terlipressin in patients with cirrhotic ascites: Pilot study
    Therapondos, G
    Stanley, AJ
    Hayes, PC
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (01) : 73 - 77
  • [9] Dynamic effects of a novel, non-peptide ADH (V2) antagonist in cirrhotic patients with ascites.
    Guyader, D
    Ellis-Grosse, EJ
    Burke, JT
    Orczyk, GP
    HEPATOLOGY, 1998, 28 (04) : 559A - 559A
  • [10] BG9719 (CVT-124) a highly potent adenosine A-1 receptor antagonist. initial experience in cirrhotic patients with diuretic refractory ascites.
    O'Beirne, JP
    Bouvier, C
    Bennett, D
    Beckman, E
    Patch, DW
    Burroughs, AK
    Hamilton, MI
    GASTROENTEROLOGY, 2000, 118 (04) : A979 - A979
12345